drug

ivosidenib

1 story · latest Nov 6, 2026

Follow ivosidenib. Every new filing, FDA action, and trial change, in your feed and a morning email, each linked to its source.

Follow free for 14 daysNo card.

Status: FDA approved Jul 2018 · NDA211192
Brand: Tibsovo

Relationships

Developed by Servier

Timeline

FDA approves ivosidenib for myelodysplastic syndromes

Nov 6Regulatory decisionivosidenib

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.